Art

J-GLOBAL ID：202002233650952601   Reference number：20A0545258

Efficacy and safety of iguratimod on patients with relapsed or refractory IgG4-related disease

再発または難治性IgG4関連疾患患者に対するイグラチモドの有効性と安全性【JST・京大機械翻訳】

Author (11)： Liu Yanying (Department of Rheumatology and Immunology, Peking University People’s Hospital, Beijing, China) ,  Zhang Yuxin (Department of Rheumatology and Immunology, Peking University People’s Hospital, Beijing, China) ,  Bian Wenjie (Department of Rheumatology and Immunology, Peking University People’s Hospital, Beijing, China) ,  Fu Jiangnan (Department of Rheumatology and Immunology, Peking University People’s Hospital, Beijing, China) ,  Sun Xing (Department of Rheumatology and Immunology, Peking University People’s Hospital, Beijing, China) ,  Chen Da (Department of Rheumatology and Immunology, Peking University People’s Hospital, Beijing, China) ,  Chen Jiali (Department of Rheumatology and Immunology, Peking University People’s Hospital, Beijing, China) ,  Zhao Xiaozhen (Department of Rheumatology and Immunology, Peking University People’s Hospital, Beijing, China) ,  Li Yingni (Department of Rheumatology and Immunology, Peking University People’s Hospital, Beijing, China) ,  Zhang Wen (Department of Rheumatology and Immunology, Peking Union Medical College Hospital, Beijing, China) ,  Li Zhanguo (Department of Rheumatology and Immunology, Peking University People’s Hospital, Beijing, China)
Material： Clinical Rheumatology
Volume： 39  Issue： 2  Page： 491-497  Publication year： 2020 
JST Material Number： W4168A  ISSN： 0770-3198  Document type： Article
Article type： 原著論文  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Abstract/Point： Abstract: Objective: To evalu...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A0545258&from=J-GLOBAL&jstjournalNo=W4168A") }}

Thesaurus term： *immunoglobulin G ,  serum ,  side effect ,  remission ,  therapeutic planning ,  base line ,  refractory ,  salivary gland ,  effectiveness ,  ultrasonic wave ,  immunosuppressant ,  amino acid ,  aliphatic amine ,  nitrogen heterocyclic compound ,  aromatic amine ,  aromatic carboxylic acid ,  enzyme inhibitor ,  aliphatic carboxylic acid ,  carboxamide ,  aminocarboxylic acid ,  tertiary amine ,  amine ,  oxygen heterocyclic compound ,  organochlorine compound ,  inorganic acid ester ,  phosphorus heterocyclic compound
Semi thesaurus term： *免疫グロブリンG4 , 【Automatic Indexing@JST】

Author keywords (5)： IgG4-related disease ,  Iguratimod ,  Refractory ,  Replase ,  Treatment

JST classification (5)： Clinical application of vasoactive drugs and hypotensive drugs  (GW07050U) ,  Cardiovascular system diseases  (GJ03000C) ,  Musculoskeletal diseases  (GG03000T) ,  Clinical application of anti-inflammatory drugs  (GW15020E) ,  Drug therapy(=pharmacotherapy)for musculoskeletal diseases  (GG05020D)

Substance index (2)： Methotrexate ,  Cyclophosphamid

Terms in the title (6)： 再発 ,  IgG4関連疾患 ,  患者 ,  イグラチモド ,  有効性 ,  安全性